4.7 Article

Patient's perspective in clinical practice to assess and predict disability in multiple sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis

Brian C. Healy et al.

Summary: Patients transitioning from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) showed deficits in Quality of Life (QOL) and fatigue prior to the transition. During the transition, patients worsened in terms of SF-36 Role Physical, Social Functioning, and Physical Component Summary. Compared to matched subjects, transitioning patients had worse scores on outcomes including Physical Functioning, Physical Component Summary, fatigue, and depression.

QUALITY OF LIFE RESEARCH (2022)

Review Clinical Neurology

Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis A Systematic Review and Meta-analysis

Stefano Floro et al.

Summary: This study evaluated the reliability of chitinase 3-like 1 (CHI3L1) as a biomarker of multiple sclerosis (MS) through a systematic review and meta-analysis. The results suggest that CSF levels of CHI3L1 have a strong correlation with the pathologic course of MS, particularly with the mechanism of disease progression.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Article Clinical Neurology

Microstructural Changes in the Left Mesocorticolimbic Pathway are Associated with the Comorbid Development of Fatigue and Depression in Multiple Sclerosis

Miklos Palotai et al.

Summary: The study found that in patients with multiple sclerosis (MS), fatigue and depression were associated with microstructural changes in the left mesocorticolimbic reward pathway (slMFB), which may contribute to the comorbid development of fatigue and depression.

JOURNAL OF NEUROIMAGING (2021)

Article Clinical Neurology

Potential Role of CHI3L1+Astrocytes in Progression in MS

Laura Cubas-Nunez et al.

Summary: The study evaluated biomarkers NfL and CHI3L1 in demyelinating diseases like MS, NMO, and ADEM, finding increased CSF NfL during clinical attacks and elevated CHI3L1 levels in NMO, ADEM, and progressive MS patients. CHI3L1 expression in macrophages and astrocytes was associated with active demyelination and neurodegeneration. The study provides Class III evidence that CSF NfL and CHI3L1 levels increase during acute inflammation in inflammatory brain diseases.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Review Clinical Neurology

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

Nik Krajnc et al.

Summary: Conversion to secondary progressive disease course in multiple sclerosis is a crucial factor for long-term prognosis, with both inflammation and neurodegeneration playing roles in the disease process. The current delay in diagnosing SPMS highlights the need for reliable biomarkers to predict and define this conversion.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium

Caila B. Vaughn et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region

Natali Farran et al.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)

Review Clinical Neurology

Review: Patient-reported outcomes in multiple sclerosis care

Emanuele D'Amico et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Article Clinical Neurology

Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS

Irene Hakansson et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Review Clinical Neurology

Cognition in multiple sclerosis: State of the field and priorities for the future

James F. Sumowski et al.

NEUROLOGY (2018)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Medicine, General & Internal

Multiple sclerosis

Massimo Filippi et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Clinical Neurology

Depression and fatigue in patients with multiple sclerosis

Emily E. Greeke et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Clinical Neurology

Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis

Salim Chahin et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)

Article Clinical Neurology

Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis

C. Gobbi et al.

MULTIPLE SCLEROSIS JOURNAL (2014)

Article Health Care Sciences & Services

Preference-based Health status in a German outpatient cohort with multiple sclerosis

Jens Peter Reese et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2013)

Article Health Care Sciences & Services

Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study

Karine Baumstarck et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2013)

Article Clinical Neurology

Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria

Chris H. Polman et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis

J. J. Kragt et al.

MULTIPLE SCLEROSIS JOURNAL (2006)

Article Clinical Neurology

Natural history of multiple sclerosis: a unifying concept

C Confavreux et al.

Article Clinical Neurology

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

N Tellez et al.

MULTIPLE SCLEROSIS JOURNAL (2005)

Article Clinical Neurology

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

R Bakshi et al.

MULTIPLE SCLEROSIS JOURNAL (2000)